Oral octreotide administered in combination with other therapeutic agents

• 收藏
• 分享

专利权人:

Chiasma Inc.;Roni Mamluk;Dana Gelbaum

发明人:

Mamluk, Roni,Gelbaum, Dana,Haviv, Asi

申请号：

AU2020239738

公开号：

AU2020239738A1

申请日:

2020.09.24

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020239738A120201015.pdf#####ABSTRACT This invention relates to combination therapy of a subject suffering from acromegaly. The method of treatment comprises administration to the subject of a therapeutically effective amount of oral somatostatin receptor ligand (SRL) e.g. octreotide in combination with a therapeutically effective amount of a dopamine agonist and/or a growth hormone receptor antagonist and/or a selective estrogen receptor modulator (SERM) and/or a 2 somatostatin receptor ligand (SRL). 22

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/